Relay Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Updates

Go back to Relay Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Updates
(NASDAQ: RLAY) Delayed: 18.19 -0.65 (3.45%)
Previous Close $18.84    52 Week High
Open $19.07    52 Week Low
Day High $19.17    P/E N/A 
Day Low $18.05    EPS
Volume 3,029,897       

(NASDAQ: RLAY) Delayed: 18.19 -0.65 (3.45%)
Previous Close $18.84    52 Week High
Open $19.07    52 Week Low
Day High $19.17    P/E N/A 
Day Low $18.05    EPS
Volume 3,029,897